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aortic neck may predispose to incomplete AAA exclusion,
resulting in aneurysm expansion or proximal stent migra-
tion or being associated with the risks of thromboem-
bolism.3-9 Other exclusion criteria include the presence of
a short aortic neck (< 1.5 cm) and an aortic neck diame-
ter greater than 28 mm2.
In this article, we analyze our experience with
endovascular grafting in 19 patients with AAAs having
defined mural filling defects within the aortic neck. All
patients underwent endovascular repair through use of a
custom-designed device that has been described in detail
elsewhere.10 The results of our experience using this
device were analyzed with regard to the following out-
comes: primary proximal endoleak, delayed endoleak,
graft migration, and thromboembolization.
MATERIAL AND METHODS
Of a total of 268 patients undergoing endovascular
repair of AAAs, 19 (7%; 17 men; mean age, 71 years) were
found to have intraluminal filling defects within the proxi-
mal aortic neck. There was no significant difference in neck
angulation between patients in this study group and those
without neck thrombus. Patients with significant cardiac
and pulmonary comorbidities, which would have placed
Endovascular grafts are being tested for the treatment
of abdominal aortic aneurysms (AAAs). The advantages of
endovascular grafting techniques in comparison with con-
ventional aortic repair include a minimum amount of dis-
comfort to the patient, the potential for fewer postoperative
cardiopulmonary complications, and reduced hospital
stay.1,2 However, not all AAAs may be amenable to repair
with currently available endovascular devices. The use of
commercial endografts in current US-based clinical trials is
limited by well-defined anatomical criteria.
One important aortic pathology that excludes patients
from clinical trials is the presumed presence of thrombus
within the aortic neck, identified as intraluminal filling
defects on computed tomography (CT) images. It has
been suggested that the presence of thrombus within the
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Objective: Although endovascular grafts have been increasingly applied to the treatment of abdominal aortic aneurysms,
their use in clinical trials is limited by well-defined anatomical exclusion criteria. One such criterion is the presence of
thrombus within the infrarenal neck of an aneurysm, which is thought to (1) prevent the creation of a permanent
watertight seal between the graft and the vessel wall, resulting in an endoleak; (2) contribute to stent migration; and
(3) increase the risk of thromboembolism. This article summarizes our experience with endovascular abdominal aortic
aneurysm exclusion in 19 patients with large aortic aneurysms, significant medical comorbidities, and apparent throm-
bus extending into the pararenal aortic neck.
Methods: Of 268 patients undergoing abdominal aortic aneurysm repair, 19 (7%; 17 men; mean age, 71 years) demon-
strated computed tomographic and angiographic evidence of intramural filling defects at the level of the aortic neck.
In no instance did these filling defects extend above the renal arteries. Endovascular grafting was performed through
use of a balloon-expandable Palmaz stent and an expanded polytetrafluoroethylene graft, delivered and deployed under
fluoroscopic guidance. Follow-up at 3, 6, and 12 months and annually thereafter was performed with computed
tomography and duplex ultrasound scan.
Results: Spiral computed tomography and aortography revealed an irregular flow-limiting defect, occupying up to 75%
of the aortic circumference, in every case. The mean aneurysm size, aortic neck diameter, and neck length before the
procedure were 6.1, 2.43, and 1.4 cm, respectively; the mean aortic neck diameter after the procedure was 2.61 cm. No
primary endoleaks were observed after graft insertion, and no delayed endoleaks have been detected during follow-up,
which ranged from 7 to 48 months (mean, 23 months). In one patient, an asymptomatic renal artery embolus was
detected on immediate follow-up computed tomography, and in another patient, an asymptomatic posterior tibial
embolus occurred.
Conclusion: No primary endoleaks, endograft migration, or significant distal embolization were observed after endo-
grafting in patients with aortic neck thrombus. The deployment of the fenestrated portion of the stent, above the
thrombus and across the renal arteries, allows for effective renal perfusion, graft fixation, and exclusion of potential
mural thrombus from the circulation. The presence of aortic neck thrombus may not necessarily be a contraindication
to endovascular repair in select patients. (J Vasc Surg 2001;33:340-4.)
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them at high risk for conventional open repair (American
Society of Anesthesiologists class III or class IV), were
offered endovascular graft procedures. Each patient under-
went spiral CT and angiography in order to properly plan
the subsequent endovascular procedure and define the
pathology. An irregular flow-limiting defect in the aortic
neck occupying greater than 75% of the aortic circumfer-
ence was seen on CT scanning in each case. The maximum
thickness of the thrombus (impingement on aortic lumen)
was 3 mm. Aortic aneurysms ranged in diameter from 5.2
to 7.8 cm (mean, 6.1 cm); the mean aortic neck diameter
and neck length were 2.43 and 1.4 cm, respectively.
Patients were considered for endografting in accor-
dance with an investigator-sponsored Investigational Device
Exemption from the US Food and Drug Administration
after informed consent was obtained. Under spinal/
epidural anesthesia, aortounifemoral stent grafts, each com-
posed of a P5014 Palmaz balloon-expandable stent (Cordis
Endovascular/Johnson & Johnson, Warren, NJ) and a
polytetrafluoroethylene graft (Impra, Tempe, AZ) (Fig 1),
were mounted onto an angioplasty balloon within a 23Fr
delivery sheath. A gold marker affixed to the margin of the
graft at the site of attachment to the Palmaz stent facilitated
radiographic localization and graft placement with respect
to the lowest renal artery. Endovascular grafts contained
within the delivery catheter were advanced over a 0.038-in
Amplatz superstiff guidewire to the pararenal segment of
the aorta. A diagnostic catheter was inserted through the
contralateral femoral artery and positioned within the aorta
to permit dynamic angiography for precise device position-
ing before deployment.
The delivery catheter containing the endograft was
retracted caudally, and the graft was finally positioned
within the aorta before deployment in such a way that the
gold marker on the graft margin was aligned with the infe-
rior border of the lowest renal artery. In every patient, this
position allowed the open portion of the stent to extend
across the orifices of both renal arteries while permitting
blood flow through the stent interstices.11 Twenty-four mil-
ligrams of adenosine was administered to each patient to
induce a short (7- to 10-second) period of asystole before
balloon inflation to ensure that the graft would not migrate
caudally during balloon expansion and stent deployment.12
The contralateral common iliac artery was occluded with a
Parodi-type occluding stent; this permitted pelvic visceral
perfusion through the internal iliac artery ipsilateral to the
common iliac occlusion. Cross-pelvic and contralateral
femoral perfusion was accomplished through placement of
a femorofemoral bypass graft constructed with a Vantage
Dacron graft (Meadox Medical, Natick, Mass) having a
diameter of 8 mm. In each patient, intraoperative comple-
tion angiography of the pararenal aorta, endograft, and out-
flow femoral vessels was performed in two views. Follow-up
examination was performed through use of dynamic, intra-
venous contrast-enhanced CT angiography.
All patients underwent examination at 3, 6, and 12
months and annually thereafter. The scanner used for the
examination was a GE Cti (General Electric, Milwaukee,
Wis). A C-minus examination result was followed by the
administration of 130 mL of intravenous contrast
(Omnipaque, 240); CT angiography was then performed
through use of 3-mm cuts, the pitch ranging from 1.5 to 3.
In addition, each patient underwent color-flow duplex scan
imaging at these time points. Aneurysm size was measured
as cross-sectional diameter on multiple CT scans (performed
identically preoperatively and postoperatively) and compared
slice by slice. No significant increases in sac diameter were
noted, and volume calculations were not performed.
RESULTS
Nineteen patients with intraluminal filling defects
diagnosed on CT scan and occupying greater than 75% of
the circumference of the aortic neck were treated with
endoluminal stent grafting for exclusion of their AAAs
(Fig 2). The mean aortic neck diameter increased slightly
after insertion of the device, from 2.43 to 2.61 cm (7.4%).
No early endoleaks were detected by means of angiogra-
phy at the completion of the procedure or within 1 week
on dynamic, contrast-enhanced CT.
No delayed endoleak or graft migration was seen in
any of the patients during follow-up, which ranged from 7
to 48 months (mean, 23 months). Furthermore, no
increase in aneurysm sac size was noted. After the proce-
dure, the immediate, 30-day, and late survival rates were
each 100% in this study group.
Two cases (10%; 2/19) of asymptomatic thromboem-
bolism were seen. Renal artery embolization secondary to
proximal graft deployment was diagnosed on the basis of a
wedge-shaped infarct on postoperative CT scanning in one
patient; there were no associated changes in creatinine, back
pain, hematuria, or development of new-onset hypertension
in this patient. Another patient was noted to have a decrease
in the left posterior tibial pulse, which was asymptomatic.
DISCUSSION
Several factors account for the strong interest in the
use of endovascular grafts for the treatment of AAAs. The
potential for a less invasive treatment allows a patient with
Fig 1. All patients recruited into the study underwent endovas-
cular repair through the use of a handmade device composed of a
balloon expandable Palmaz stent sutured to tapered PTFE graft.
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severe medical comorbidities to have aneurysm exclusion,
possibly eliminating the risks of rupture. More important,
it makes possible the treatment of patients with cardiac
and pulmonary disease that would have otherwise pre-
cluded conventional repair. In addition, recent reports
have documented the average length of stay for endovas-
cular aneurysm repair at 4.1 ± 2.6 days; this compared
with 8.8 ± 4.1 days for a control group of patients who
underwent open aneurysm repair (P < .05).1 Similar find-
ings have been reported in another large prospective
study, with a mean length of stay of 3.4 ± 2.7 days for
endovascular repair versus 9.4 ± 2.7 days for conventional
open aneurysm repair (P < .01).2
The use of endovascular grafts in these US-based clin-
ical trials is limited by well-defined anatomical exclusion
criteria. The presence of thrombus within the infrarenal
aortic neck of an aneurysm is considered a contraindica-
tion for endovascular repair for three principal reasons.
First, it is widely believed that thrombus at the aortic
neck will prevent a watertight seal of the stent graft against
the aortic luminal surface, thus allowing endoleakage of
blood and not effectively excluding the aneurysm.
Persistent endoleaks contribute to aneurysm expansion
and potentially to their ultimate rupture.3-5 Moreover, late
lysis of the thrombus may allow channel formation around
a previously intact seal of the device against the aortic wall,
resulting in a delayed endoleak, aneurysm expansion,
device migration, and risk of rupture.
Second, there may be ineffective purchase of the stent
in the thrombus,6-8 leading to immediate device migra-
tion. In a series published by Chuter et al,7 every case of
device migration was associated with one of the following
factors: the neck was less than 10 mm in length; the neck
was lined with thrombus; or the device was implanted
more than 15 mm from the renal neck. Other investiga-
tors have reiterated this finding, reporting that nearly 20%
of stent graft migrations occur in association with throm-
bus-lined proximal aortic necks.6
Third, there is concern that in the presence of proxi-
mal aortic neck thrombus, there is a greater risk of distal
embolization than may be engendered by the obligatory
intraluminal manipulation of the sac contents by the
guidewires and devices during the positioning and deploy-
ment phases of the endovascular procedure. A recent
study has shown that endovascular repair is accompanied
by a nearly threefold increase in embolic events in com-
parison with open repair.9
CT scans are routinely used by most centers, including
our own, both for screening and for planning of the appro-
priate therapeutic intervention in patients presenting with
an AAA. It is well recognized that CT scanning is a useful
diagnostic modality for monitoring the progression and
regression of atherosclerosis in the descending thoracic
aorta.13,14 More recent literature has emphasized the use-
fulness of CT scanning in the detection of aortic atheromas
as a source of emboli leading to stroke15; the investigators
found it comparable to transesophageal echocardiography
for the diagnosis of patients with this pathology in the tho-
racic aorta. CT scanning is also useful for the diagnosis of
patients with acute injury to the thoracic aorta.16 However,
CT scanning cannot reliably differentiate between different
components of the plaque (thrombus, fibrous tissue, lipid,
etc). This distinction is important, inasmuch as the diagno-
sis of thrombus within the aortic neck is frequently made
in CT scanning on the basis of the presence of a filling
defect. Patients with these CT-diagnosed lesions are there-
fore excluded from endovascular repair.
Magnetic resonance imaging has recently emerged as
a useful technique for differentiation of the various com-
ponents of the atherosclerotic plaque. Recent in vivo stud-
ies17 have shown its usefulness, but it is not yet widely
available in most centers. Intravascular ultrasound scan is
another imaging modality that may be useful for the peri-
operative assessment and characterization of lesions within
the aortic neck. The use of high-resolution catheters may
effectively distinguish between thrombus (echolucent on
ultrasound scan) and fibrous tissue (echogenic).18
Because CT imaging cannot give a pathologic or tis-
sue diagnosis but is instead limited to measuring relative
radiopacity, there is a strong likelihood that what is read as
“thrombus” is in fact a heterogeneous collection of mate-
rial ranging from organized thrombus to fibrous or ather-
osclerotic plaque. Although the former has a high
potential for embolization and negligible adherence to the
underlying aortic wall—thus providing an inadequate pur-
chase for the stent to anchor the graft proximally—the lat-
ter is an integral part of the vessel wall and, although
deformable, is unlikely to jeopardize stent graft fixation.
Both a short proximal neck and a neck diameter
greater than 30 mm have been implicated in complica-
tions of endovascular aortic aneurysm exclusion, espe-
cially with difficulty in achieving a seal.7 Interestingly, the
placement of stents across the renal arteries has been
shown to be well tolerated in animal experiments.19-21
Clinical studies have also shown that transrenal placement
of stents for graft fixation is not associated with deleteri-
ous side effects in patients undergoing transfemoral
endovascular aneurysm repair.11,22
The presence of thrombus within the aortic neck has
previously been considered a contraindication to endovas-
cular repair because of its association with such complica-
tions as immediate and delayed endoleaks, graft migration,
and distal embolization. The successful treatment of
patients with diagnosed thrombus in the aortic neck by
transrenal placement of stents that effectively anchor the
endograft in the infrarenal proximal aortic segment has
not been previously described.
Our experience has shown that the presence of “throm-
bus” within the aortic neck, diagnosed on the basis of CT
scanning, does not necessarily constitute a contraindication
to endovascular repair. Transrenal fixation of the stent
anchoring the endovascular device, which is overdilated in
the infrarenal segment to achieve effective fixation against
the aortic wall, leads to successful exclusion of the aneurysm
in patients with these lesions. We also believe that it is the
transrenal fixation to normal suprarenal aortic tissue that has
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prevented the occurrence of early and late endoleaks in this
study population.
Although long-term results are awaited, no statistically
significant increase in aortic diameter was noted during the
follow-up period. Two patients (10%) were diagnosed as
having asymptomatic thromboembolism. One of these
patients acutely developed CT evidence of renal emboliza-
tion, although this was not associated with biochemical evi-
dence of deterioration in renal function or the development
of hypertension. The etiology of this embolus, which is
unclear, is presumed to be a result of cephalad displacement
of aortic neck material. The second patient experienced an
asymptomatic diminution in a pedal pulse. No other evi-
dence of procedure-related thromboembolism was detected.
Fig 2. A, Angiogram shows infrarenal aneurysm measuring 6.2 cm. Aortic neck diameter is 2.2 cm (irregular); aortic neck length is 1.5 cm.
Arrow points to site of penetrating aortic ulcer. B, Intraoperative angiogram in same patient shows optimal positioning and deployment of
balloon-expandable endovascular graft. Endovascular stent graft is positioned in such a way that marker on cephalad end of graft (a) is at level
of left (lowest) renal artery (b). This positioning was chosen specifically to exclude previously identified penetrating aortic ulcer (c). C,
Completion angiogram shows deployment of balloon-expandable endograft. Renal artery perfusion through open portion of stent interstices
is apparent. Penetrating aortic ulcer and surrounding aortic neck irregularities have also been successfully excluded. D, CT scans taken before
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Previous investigators have reported a higher incidence
of proximal endoleaks and device migration secondary to
endovascular device deployment in patients with throm-
bus-lined aortic necks; this has been explained on the basis
of poor purchase of the device after deployment within the
thrombus. In the current series of 19 patients, no early or
delayed endoleaks were detected. This may be due to effec-
tive stent deployment and seating in the thrombus-free
transrenal and suprarenal segments of aorta.
We therefore think that the presence of an intraluminal
filling defect on a preoperative CT scan may unnecessarily
preclude patients from selection for endovascular repair
because of the technical limitations of this otherwise indis-
pensable diagnostic imaging tool. Such exclusion has the
principal disadvantage of preventing access to endovascular
repair for a large population of patients who may otherwise
benefit from this minimally invasive approach. The early
follow-up results of this experience have shown that the
fears articulated by several current commercial protocols
about endovascular repair in the setting of proximal aortic
neck thrombus may not be as well justified as was once
thought. However, such patients should be approached
with the understanding that they are at increased risk of
thromboembolization during device deployment, and this
risk may be similar to or greater than that seen in compa-
rable patients undergoing open repair. As with any novel
technique, favorable long-term follow-up will establish the
role of endovascular aortic repair in patients with signifi-
cant contraindications to open repair, aortic neck thrombi,
and “short” (< 15 mm) necks.
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